Company · CIK 1845459
NKGen Biotech, Inc.
| CIK | 1845459 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2836 — Biological Products, (No Diagnostic Substances) |
| Incorporated in | DE |
| Business address | CA |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2021-07-02 |
Offerings
2 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-275094 | 2023-10-19 | 2024-07-08 | 6 | |
| 333-253411 | 2021-02-23 | 2021-05-24 | 5 |
Filings
12| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-07-08 | EFFECTDeclared effective | 333-275094 | 9999999995-24-002089 |
| 2024-06-27 | S-1/AAmendment | 333-275094 | 0001213900-24-056687 |
| 2024-05-13 | S-1/AAmendment | 333-275094 | 0001213900-24-042376 |
| 2023-12-15 | S-1/AAmendment | 333-275094 | 0001104659-23-126438 |
| 2023-11-29 | S-1/AAmendment | 333-275094 | 0001104659-23-122107 |
| 2023-10-19 | S-1Registration filed | 333-275094 | 0001104659-23-110175 |
| 2023-08-14 | EFFECTDeclared effective | 333-271929 | 9999999995-23-002371 |
| 2021-05-24 | 424B4Final prospectus | 333-253411 | 0001104659-21-071299 |
| 2021-05-20 | EFFECTDeclared effective | 333-253411 | 9999999995-21-002033 |
| 2021-05-05 | S-1/AAmendment | 333-253411 | 0001104659-21-061275 |
| 2021-04-12 | S-1/AAmendment | 333-253411 | 0001104659-21-049393 |
| 2021-02-23 | S-1Registration filed | 333-253411 | 0001104659-21-026802 |